Sherry Farrugia Selected by GCMI Board of Directors as Permanent CEO


Sherry Farrugia

Sherry Farrugia

Sherry Farrugia has been selected by the Global Center for Medical Innovation (GCMI) board of directors as the organization’s permanent CEO, effective April 1, 2021. Farrugia had been serving as interim CEO for GCMI, a Georgia Tech affiliate, since September 2020.

“We are so pleased to congratulate Sherry as she joins GCMI in this permanent capacity,” said Chaouki T. Abdallah, Georgia Tech’s executive vice president for Research. “She was a steadfast advocate, innovator, and leader in her time at Tech and I know she will bring that same dedication to the important, transformational work of GCMI.”

Farrugia came to GCMI from the Children’s Healthcare of Atlanta Pediatric Technology Center at Georgia Tech, where she served as chief operating and strategy officer for 10 years, focusing on accelerating innovation for pediatrics. During that time, Farrugia worked with GCMI on numerous projects. Recently, she played a key part in GCMI’s success supplying frontline healthcare workers with personal protective equipment during the pandemic.

“Sherry Farrugia is nationally recognized for her work in advancing translational medical research, and we are excited that she will continue with GCMI as permanent CEO,” said Bob Crutchfield, chair of the GCMI board of directors and CEO of TeleHealth Solution. “Her visionary leadership, strong community ties, and knowledge of the commercialization ecosystem and medical device strategy and development have been great assets to GCMI thus far and will be instrumental in our path forward.”

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.